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Abstract
The primary purpose of this project was to determine the knowledge of nurse
practitioners in Mississippi regarding the 2017 American Heart Association Hypertension
Guidelines. Following approval by the Institutional Review Board (IRB), the researchers
utilized a descriptive, quantitative survey design to evaluate the knowledge of Mississippi
nurse practitioners of the 2017 American Heart Association Hypertension Guidelines in
regards to diagnosis and management of hypertension. Utilizing social media, the
researchers targeted specific Facebook sites for nurse practitioners who practice in the
state of Mississippi. Data was gathered through SurveyMonkey using a questionnaire.
The data gathered from the completed questionnaires were then subjected to analysis.
Data were analyzed to determine if the nurse practitioner was knowledgeable of blood
pressure diagnosis and management according to the 2017 American Heart Association
Hypertension Guidelines. To be considered knowledgeable in management and/or
diagnosing hypertension, the provider had to score 80 percent in each portion of the
survey. More than half of the nurse practitioners who participated were considered
knowledgeable in managing hypertension according to the 2017 American Heart
Association Hypertension Guidelines. Out of the 52 surveyed, 30 nurse practitioners were
considered knowledgeable in diagnosing hypertension according to the 2017 American
Heart Association Hypertension Guidelines. 28 of the 52 practitioners were considered
knowledgeable in managing hypertension using the 2017 American Heart Association
Hypertension Guidelines. Based on the results, overall nurse practitioners are
knowledgeable of the 2017 American Heart Association Hypertension Guidelines.
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Chapter I
Dimensions of the Problem
Hypertension is a nationwide health issue that continues to rise in prevalence each
year. During 2015–2016, the prevalence of hypertension was 29.0 percent, with
percentages increasing with age; age group 18–39 was estimated to be at 7.5 percent; age
group 40–59 was estimated to be at 33.2 percent; and age group 60 and over was
estimated to be 63.1 percent (CDC, 2017). Untreated or uncontrolled hypertension can
lead to a higher risk for other health threats, such as heart attack, stroke, kidney failure,
peripheral artery disease, and many other disease processes. While controlled
hypertension is a risk factor for cardiovascular diseases, the risk can be lowered and
should be a priority for anyone with a known diagnosis of hypertension. Regular blood
pressure screening and education of what an individual’s blood pressure target range
should be is an important aspect of being a healthcare provider today. To accurately treat
patients and educate them on target blood pressure ranges, it is imperative that providers
remain current on the latest and most accurate blood pressure guidelines created
according to the most current research. Prevention of hypertension begins with the
knowledge of the recommended guidelines.
Many providers argue that the 2017 American Heart Association Hypertension
Guidelines, included in Appendix A, will only increase the prevalence of hypertension
diagnoses in America by diagnosing much lower blood pressures as hypertensive. These
healthcare providers that are not supportive of the 2017 American Heart Association
Hypertension Guidelines are more supportive of the Joint National Committee 8
hypertension guidelines that were published in 2013 (Page, 2014). The Joint National
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Committee (JNC 8) guidelines (See Appendix B), published in 2014 advise higher blood
pressure goals and less use of several types of antihypertensive medications. JNC 8 states
that in patients 60 years or older who do not have diabetes or chronic kidney disease, the
goal blood pressure level is <150/90 mm Hg, and in patients 18 to 59 years of age
without major comorbidities, and in patients 60 years or older who have diabetes, chronic
kidney disease (CKD), or both conditions, the revised goal blood pressure level is
<140/90 mm Hg. (AHA, 2017) Tables are provided in Appendices A and B comparing
the JNC 8 hypertension parameters (See Appendix B) to the AHA 2017 hypertension
parameters (See Appendix A).
The revised American Heart Association guidelines were developed with nine health
professional organizations and were published by a panel of 21 scientists and health
experts who reviewed more than 900 published studies (AHA, 2017). The American
Heart Association has stated that normal parameters for blood pressure are systolic
pressures of less than 120/80 mm Hg; elevated blood pressure parameters are systolic
pressures between 120-129 and a diastolic pressure less than 80; stage one hypertension
is defined by systolic pressures between 130-139 or diastolic pressures between 80-89;
stage two hypertension is defined by systolic pressures of at least 140 or diastolic
pressures at least 90 mm Hg; and a hypertensive crisis is defined by a systolic pressure
over 180 and/or diastolic pressures over 120 (AHA, 2017). The current project’s purpose
was to determine if primary care providers in Mississippi are knowledgeable of the 2017
American Heart Association Hypertension Guidelines. A survey with a questionnaire was
the basis of determining if these targeted providers are knowledgeable of the 2017
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American Heart Association Hypertension Guidelines, which are the most current
hypertension guidelines published.
Statement of Purpose
The purpose of this research project is to determine if primary care providers in
Mississippi are knowledgeable of the 2017 American Heart Association Hypertension
Guidelines and are using these guidelines appropriately to diagnose hypertension in their
patients, see Appendix A. The American Heart Association has stated that normal
parameters for blood pressure are systolic pressures of less than 120/80 mm Hg; elevated
blood pressure parameters are systolic pressures between 120-129 and a diastolic
pressure less than 80; stage one hypertension is defined by systolic pressures between
130-139 or diastolic pressures between 80-89; stage two hypertension is defined by
systolic pressures of at least 140 or diastolic pressures of at least 90 mm Hg; and a
hypertensive crisis is defined by a systolic pressure over 180 and/or diastolic pressures
over 120 (AHA, 2017). The 2017 American Heart Association Hypertension Guidelines
have eliminated the category of prehypertension, categorizing patients as having either
elevated (120-129 and less than 80) or stage I hypertension (130-139 or 80-89). The
earlier guidelines classified 140/90 mm Hg as stage 1 hypertension are now classified as
stage 2 hypertension under the new guidelines (AHA, 2017). With the changes made to
the guidelines, it is especially important for providers to be aware of the most current
studies and published guidelines to accurately prevent, diagnose, and treat hypertension.
Significance of the Research Project
This project is significant to primary care providers treating hypertensive patients, to
research, and to health education. Primary care providers and nurses must be aware of the
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ever-changing prevalence of hypertension and the way it affects patients so they can treat
them in the most effective way. Studies mentioned in the American Heart Association
hypertension guidelines that determine new lower guidelines for hypertension can assist
primary care providers by being more proactive in the treatment of patients, which leads
PCPs to being more proactive at preventing cardiovascular diseases (AHA, 2017).
This project is significant to research by leading the way for future research of
hypertension, which is as important as it is common. Hypertension will continue to be
researched and studied by scientists worldwide. This project can help future studies by
supplying research and statistics on the 2017 American Heart Association Hypertension
Guidelines.
This project is significant to education by providing more thorough teaching and
evaluation of knowledge of the hypertensive guidelines that can improve the quality and
efficiency of care. Education of patients is a major part of a healthcare provider’s daily
job and the new guidelines are especially important for them to educate their patients.
The new guidelines will require stricter adherence to diet and exercise to be able to lower
their blood pressure ranges. Thorough education on diet recommendations with healthier
choices, smaller portions, and less sodium-rich meals must be taught. Thorough
education will also need to be taught on appropriate exercise regimens with each patient
diagnosed with hypertension.
Theoretical Foundation
Sister Callista Roy’s Adaptation Model was the theoretical framework used in this
study. The Roy Adaptation Model is significant to this project by determining if patients
are adapting to the new changes in their treatment of a hypertension diagnosis set by the
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2017 American Heart Association Hypertension Guidelines (Jennings, K.M.,2017).
Healthcare providers may also be adapting to new diagnosing parameters, and therefore
treating their adult hypertensive patients in lower blood pressure ranges requires them to
adjust previous guidelines. Due to hypertension being such a prominent diagnosis,
healthcare providers need to be aware of the most current guidelines for hypertension to
adapt them and to provide the most efficient care to their patients. The purpose of the
Roy’s Adaptation Model of Nursing is to promote a theory of interrelated systems that
have the goal of maintaining balance between various stimuli (Jennings, K.M.,2017).
Sister Callista Roy’s Adaptation Model of Nursing was developed by Sister Callista Roy
in 1976 (Gonzales,2019). Her theory has been translated into many languages and is still
used all over the world in practice, education, and research. Roy believed in approaching
treatment for each patient with a holistic view. This model is important to society because
it encourages adaptive interventions based on prior research to uphold better nursing care
and more successful patient outcomes. The Adaptation Model of Nursing is composed of
concepts including an adaptive system that determines the way that an individual
responds to changes in his or her daily life, the environment and surrounding social and
environmental factors, an individual’s personal health including their diet, family history,
and exercise, and the goal of nursing, which is to provide care for each patient to reach
their healthiest being (Gonzales, 2019). Responding to changes in one’s daily life can be
associated with the responsibility of taking a medication every day when an individual
might not be accustomed to that and will need to adapt to that change. A patient’s
surrounding social environment could play a role in hypertensive diagnosis and treatment
by reducing the amount of social drinking and including more physical activity. An
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individual’s personal health relates to hypertensive diagnosis by requiring a change in
diet and exercise routine. Controlling hypertension is one of the aspects of providing the
best possible care for patients to help them reach their healthiest state. Roy’s Adaptation
Model assists nurse practitioners and healthcare workers in adapting to the diagnosing
and managing hypertension according to the new lower parameters set by the 2017
American Heart Association guidelines. This project’s purpose was to determine if
healthcare providers are adapting to the newest hypertension guidelines set by the
American Heart Association.
Research Questions
1. Are primary care providers knowledgeable of the 2017 American Heart
Association Hypertension Guidelines for diagnosing adult patients with
hypertension? (See Appendix A)
2. Are primary care providers knowledgeable of the 2017 American Heart
Association Hypertension Guidelines for management of adult patients diagnosed
with hypertension? (See Appendix A)
Definitions of Terms:
Primary care providers
Theoretical Definition: A healthcare provider (i.e., the nurse practitioner, physician’s
assistant, or physician) to whom a patient first goes to address a problem with his or her
health. (Venes, 2017).
Operational Definition: A licensed nurse practitioner in Mississippi that diagnoses
and manages patients with hypertension and answered the questionnaire. See Appendix
C.
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Knowledgeable
Theoretical Definition: Having or showing knowledge or intelligence. (MerriamWebster)
Operational Definition: A score of 80% or above on questions 4-8 of the Knowledge
of the 2017 American Heart Association Hypertension Guidelines Questionnaire (See
Appendix C) to be considered knowledgeable of the diagnosing of hypertension
according to the American Heart Association Hypertension Guidelines, and scoring 80%
or above on questions 9-13 of the Knowledge of the 2017 American Heart Association
Hypertension Guidelines Questionnaire (Appendix C) to be considered knowledgeable of
the management of hypertension according to the 2017 American Heart Association
Hypertension Guidelines See Appendix C.
American Heart Association
Theoretical Definition: Nation’s oldest and largest voluntary organization dedicated
to fighting heart disease and stroke. (AHA, 1924)
Operational Definition: an organization that provides the latest guidelines for
treatment and management of hypertension to medical providers, with the last update on
hypertension guidelines being formed in 2017. See Appendix A.
Hypertension Guidelines
Theoretical Definition: Guidelines that define a condition in which the blood pressure
(BP) is higher than 140 mm Hg systolic or 90 mm Hg diastolic on three separate readings
recorded several weeks apart (Venes, 2017).
Operational Definition: According to the 2017 American Heart Association
Hypertension Guidelines normal parameters for blood pressure is a systolic pressure of
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less than 120/80 mm Hg; elevated blood pressure parameters are systolic pressures
between 120-129 and a diastolic pressure less than 80; stage one hypertension is defined
by systolic pressures between 130-139 or diastolic between 80-89; stage two
hypertension is defined by systolic pressures at least 140 or diastolic at least 90 mm Hg;
and hypertensive crisis is defined by a systolic pressure over 180 and/or diastolic over
120. (See Appendix A)
Diagnosing
Theoretical Definition: Identify the nature of an illness or problem by examination of
symptoms. (Merriam-Webster)
Operational Definition: A problem identified after subjective, objective, and physical
exam performed on a patient.
Adult Patient
Theoretical Definition: One who is sick with or being treated for, an illness or injury
(Venes, 2017).
Operational Definition: A person that is being seen by a nurse practitioner for a
diagnosis of hypertension and is the age of 18 and above.
Management
Theoretical Definition: The process of dealing with or controlling things or people.
(Merriam-Webster)
Operational Definition: Pharmacological treatment with medications and
nonpharmacological treatment with lifestyle modification recommendations for patients
diagnosed with hypertension.
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Assumptions
For the purpose of this study, the assumptions were as follows:
1. Nurse practitioners are knowledgeable of the 2017 American Heart Association’s
Guidelines in their daily practice and management of hypertension.
2. The questionnaire can determine if nurse practitioners are knowledgeable of the
2017 American Heart Association’s Guidelines.
3. The nurse practitioners completing the questionnaire were truthful with their
answers to the questionnaire.
Summary

The questionnaire completed by nurse practitioners in Mississippi was to determine if
primary care providers in Mississippi are knowledgeable of the 2017 American Heart
Association Hypertension Guidelines with respect to diagnosing adult hypertensive
patients and management of adult hypertensive patients. This chapter also discussed the
significance to nursing, research, education, and theory.
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CHAPTER II
Review of Literature
Hypertension is a nationwide health problem that continues to be an issue each
year. Untreated or uncontrolled hypertension can lead to a higher risk for other health
threats such as heart attack, stroke, kidney failure, peripheral artery disease, and many
other disease processes. The purpose of this research project was to determine if primary
care providers in Mississippi are knowledgeable of the 2017 American Heart Association
hypertension Guidelines to diagnose and manage patients with hypertension. There is
controversy between healthcare providers that support the 2017 American Heart
Association/ American College of Cardiology (AHA/ACC) (See Appendix A) guidelines
versus those who are in support of the Eighth Joint National Committee (JNC8)
guidelines (See Appendix B). Research studies were reviewed to determine various
methods of hypertension management. The researchers also reviewed literature from
Sister Callista Roy’s Adaptation Model and utilized her adaptation model as the
framework for the research project. Her model was chosen to examine how the primary
care providers are evolving to the new guidelines provided by the AHA/ACC. Chapter
two will review how the literature correlates with what is recommended by the American
Heart Association.
Literature Related Review
Sister Callista Roy’s Adaptation Model was the theoretical framework used for
this research project. Based on Sister Roy’s Adaptation Model, adaptation to different
stimuli is important for individuals to grow and change. This theory is applied to the
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current research project to see if primary care providers were able to change and adapt to
the new guidelines provided by the American Heart Association. There have been
numerous projects done to review the Adaptation Model to identify how people adapt to
different stimuli. Adibelli et al. (2018) completed a study to evaluate patients diagnosed
with hypertension who were provided with education management by using the Roy’s
Adaptation Model. According to Roy’s Adaptation Model, it is important that patients
with hypertension be proactive in their own health wellness.
The hypothesis of the Adibelli et al. (2018) study was to evaluate the
effectiveness of education in patients diagnosed with hypertension using Roy’s
adaptation model for hypertensive management. This would provide confirmation of the
effectiveness of the teaching provided to patients with hypertension when applied to their
health.
The methods used in this study were a pre-test, a post-test, and a quasiexperimental design with a control group. The study was completed in family health
centers in Erzurum city. There were seven family health centers used in the study that had
patients diagnosed with hypertension. These patients were thirty-five years old and older
and were able to perform their activities of daily living independently. The study
consisted of 155 patients with hypertension who were able to perform their daily living
activities independently (Adibelli et al., 2018). 75 patients were randomly selected for
the experimental group to visit the family center on Wednesday. Another 80 patients
were randomly selected for the control group to visit on Thursday. The pre-test was given
in face-to-face interviews during home visits, along with an explanation of the study. An
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effective health education method was used for the experimental group; the group
members were also given home visits that the researchers believed to be more effective
and created a positive rapport between the educator and the patient. In the education
portion of the research, the presentations were based on Roy’s adaptation model and
utilized the hypertension management guide that the researchers prepared. There were
numerous sessions which used different areas of Roy's model. At the end of the program,
the participants were given a booklet that was considered a refresher for them to be able
to reference in times of uncertainty. The post-test was completed two months after all the
interventions were given. There were not any educational interventions given to the
control group except for the same educational booklet that was given to the experimental
group.
Groups that were identified in the experimental group of this study included the
following: 86.7% of the participants were nonsmokers, and of those patients, 50.7% had
other diseases along with hypertension; 77.3% used their medications routinely. There
was no difference between the disease characteristics in either the experimental or control
groups. The pre- and post-test scores of the self-efficacy scale for adherence/ adaptation
to medical treatment were not statistically significant. Of the hypertensive management,
the difference between the control and experimental group’s mean scores were drastically
different. The experimental group scores of the Self-Efficiency scale for
Adherence/Adaptation increased after their participation in the education program
(Adibelli et al., 2018). This would support Roy’s theory of adaptation, which proves that
adaptation is crucial for health improvement.
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The Adibelli et al. (2018) research study was relevant to the research project
because it showed the importance in using Roy’s Adaptation Theory with hypertension
patients. It was noted that adaptation was beneficial for detection, prevention, and
treatment of hypertension. This gave Adibelli et al. (2018) something to build upon and
to compare from an educational point of view. It also allows future researchers to see
how important education and adaptation is in treating and managing hypertension. This
research was very helpful in guiding the current research study because a strong
foundation of Roy’s Adaptation Model was demonstrated through the reviewed study.
The Adibelli et al. (2018) study suggests that education based on Roy’s adaptation model
can influence desired outcomes for patient care. It is suggested that using the Roy model
should be considered in clinical practice.
Mohaissen et al. (2020) conducted a research study with the goal of determining
the impact of the 2017 ACC/AHA (See Appendix A) hypertension guidelines on the
prevalence and diagnosing of hypertension in young Saudi women. The new diagnostic
cut-off value defined by the American Heart Association Hypertension Guidelines of
≥130/80 mmHg is to replace the previous Seventh Joint National Committee guidelines
(See Appendix D) threshold of ≥ 140/90 mmHg for the diagnosis of hypertension. The
research conducted in this study was to determine the effects of this new diagnostic cut
off. Data collections were based on a questionnaire as the method of study for this
project.
Mohaissen, et al. (2020) identified a single hypothesis, which was that the
prevalence of hypertension markedly increased among young adult Saudi women with
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the 2017 ACC/AHA (See Appendix A) classification for hypertension, and the main
predictors were increased BMI and heart rate. The data for this study came from reanalyzing the results of 518 adult Saudi females between the ages of 17–29 years old who
participated in a hypertension survey conducted in 2016 on undergraduate and
postgraduate students at Princess Nourah Bint Abdulrahman University, Riyadh after
introducing the new diagnostics defined by the 2017 ACC/AHA guidelines (See
Appendix A). Participants were chosen within a time frame of January 2016 to April
2016. After gaining approval from the Institutional Review Board, the researchers
dispersed anonymous questionnaires comprising 65 questions assessing sociodemographic characteristics, blood pressure history, and risk factors for hypertension. To
begin the studies, participants’ blood pressures were taken and documented using the
National Health and Nutrition Examination Survey instructions. Three brachial BP
readings were taken at 5-minute intervals for each participant while resting, recording the
average of the second two readings, and discarding the first reading. Mohaissen, et al.
(2020) compared the differences in the prevalence of hypertension as diagnosed with the
2017/ACC/AHA (See Appendix A) with the JNC7 (See Appendix D) guidelines using
McNemar’s test. The researchers analyzed the data using SAS, version 9.4.
Following analysis, the researchers determined that the first hypothesis was
statistically correct. Using the 2017/ACC/AHA (See Appendix A) classification, 27.1%
of participants would be classified as having hypertension, which is significantly higher
than the prevalence of 4.1 percent if the JNC7 (See Appendix D) classification was used.
Mohaissen, et al. (2020) found that 85% of the hypertensive patients in this study had
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stage 1 hypertension (systolic BP = 130– 139 mmHg and/or diastolic BP = 80–89
mmHg), and 15 percent had stage 2 hypertension (BP ≥ 140/90 mmHg). The results from
this study show a 7-fold increase in hypertensive diagnoses correlating with the earlier
treatment of hypertension, which is expected to eventually reduce the presence of
cardiovascular mortality and morbidity.
The study was relevant to the current research project for several reasons. The
basis of the study was hypertension screening in society. The study bolsters the
hypothesis that hypertension cases based on the new classification will increase
prevalence of the disease and management burden on the healthcare system requiring
more interventions and education by healthcare providers, not only in Saudi Arabia but
also in the United States as well. With supporting evidence from other research showing
that lower blood pressure values result in reduced mortality and morbidity, establishing
the true likelihood of hypertension and its risk factors in the community, particularly
among the young, is a necessity.
Choi et al. (2019) completed a study to compare all-cause and cardiac mortality
using the JNC7 (See Appendix D) and the 2017 ACC/AHA guidelines (See Appendix A).
For this study, the National Health Insurance System-National Health Screening Cohort
(NHIS-HEALS) and Korea National Health, and Nutrition Examination Survey
(KNHANES) were utilized to gather data for comparison. Blood pressure ranges were
classified into three separate groups according to both sets of guidelines, and survival
rates were analyzed with Kaplan-Meier curves and log-rank tests. Blood pressure ranges
from the JNC7 (See Appendix D) guidelines differentiated the hypertension group to

24
blood pressures of ≥140/90 from the prehypertension group which had blood pressures of
130/80–139/89 and normal blood pressures as <130 and <80. On the contrary, the 2017
ACC/AHA guidelines (See Appendix A) showed inconsistent survival outcomes
according to blood pressure ranges classification of normal blood pressure being: <120
and <80, and elevated blood pressures being: 120–129, and <80, and hypertension being
diagnosed when ranges are: ≥130/80).
Study populations were followed from January 1, 2006, until the date of a
cardiovascular event, death, or December 31, 2015, whichever would occur first. The
authors gathered 1,021,208 participants aged 30–74 years whose data were available and
excluded individuals who met any of the following criteria (n = 878,590): Younger than
30 or older than 75 years of age; history of hospitalization for a diagnosis of myocardial
infarction or stroke, any type of malignant cancer; death in the year of enrollment; single
medical record after 2006; and those with missing SBP, DBP, or death data. After these
exclusion criteria eliminated many participants, the authors were left with 142,618
participants. Blood pressures were measured at local hospitals, each of which met the
internal and external quality control procedures of the Korean Association of External
Quality Assessment Service. After participants were required to rest while seated for at
least 2 minutes, the blood pressures were taken by digital or automatic monitors during
the health examination. All blood pressure measurements, including blood pressure data
before the index period, were used to calculate mean blood pressures. The results were
able to support that the increase in hypertension diagnosis was around 40.64 percent and
44.8 percent based on the 2017 AHA/ACC guidelines (See Appendix A). These results
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were an increase compared to the 9.64 percent and 18.4 percent according to the
guidelines from JNC7 (See Appendix D).
This study consisted of several limitations. First, although blood pressure
measurement equipment in all health examination institutions received quality
assessment, the lack of device uniformity and single visit measurements may have
included some variability into the results. Second, the Choi et al. (2019) study utilized
factors that could result in over- or under-estimation of the effect of blood pressures on
clinical outcomes. Third, there was not an account for antihypertensive medications that
may affect the all-cause or cardiovascular mortality and could not confirm whether those
who took antihypertensive medications following the JNC7 (See Appendix D) had a
significantly lower mortality than those following the 2017 ACC/AHA guidelines (See
Appendix A).
Although the recent 2017 ACC/AHA guidelines (See Appendix A) recommend
treating patients to reduce systolic blood pressure to be <130 mm Hg and diastolic blood
pressure to be <80 mm Hg, it is still unclear whether aggressive blood pressure control
results in improved clinical outcomes. In contrast to the 2017 ACC/AHA guidelines (See
Appendix A), the JNC7 (See Appendix D) guidelines demonstrated a linear association
between blood pressure levels and cardiovascular survival outcomes in two nationwide
datasets as well as good discrimination ability in all survival outcomes. Altogether, the
results suggest that the JNC7 (See Appendix D) guidelines are more appropriate than the
2017 ACC/AHA guidelines (See Appendix A) in Korean populations.
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This is relevant to the current research project because it makes note of why some
healthcare providers are in support of the Joint National Commission guidelines rather
than the American Heart Association’s recommendations. If hypertension cases are based
on the new classification, it will increase disease diagnoses and strengthen the burden that
is placed on healthcare providers.
Tocci et al. (2020) performed a study to investigate whether patients were being
treated for hypertension based on the most recent European guidelines. This research
study conveyed that in less than five years, approximately 1.4 billion people would be
affected by hypertension and that more than 54% of deaths from ischemic heart disease
worldwide would occur due to uncontrolled hypertension. The new guidelines from the
European Society of Cardiology/European Society of Hypertension (ESC/ESH) were
redefined. According to these new guidelines, the optimal systolic/diastolic BP goals
should be 130-139/70-79 mmHg in individuals aged >65 years and <130 mmHg or
lower, if tolerated (not <120 mmHg), in those aged 18-65 years, with the only exception
of CKD patients, in which systolic BP treatment target should be <140 mmHg to 130
mmHg. The guidelines from the ESC/ESH are comparable to the ACC/AHA guidelines
(See Appendix A) with similar parameters. This research group wanted to see if office
blood pressures were being treated and diagnosed following the new guidelines.
The researchers set out to seek a real-life appraisal of blood pressure control in
three European hypertension centers. These researchers wanted to determine if the
current practice was using the new guidelines and if not, how old were the guidelines that
were being used. The methodologies of this study were observational, cross-sectional,
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and multicenter. Information was gathered from three excellence centers for hypertension
located in low-risk areas of Southern Europe. The data was collected onsite via online
access to a remote database. Data collection took place between January and April 2019.
Blood pressures were obtained in the morning, after five minutes of rest, on the same
arm, in a sitting position while in a quiet room, and using validated devices as
recommended by the European guidelines. Three blood pressures were taken. The
average of the three blood pressure measurements were considered the clinic
systolic/diastolic levels. The average of the three measurements determined if the blood
pressure was elevated or not.
A sample size of 14,229 individuals underwent assessment or follow-up for a
blood pressure assessment. Of these individuals, 4,049 were in the normotensive area,
3,088 were untreated hypertensive patients; and 7,092 were receiving antihypertensive
drug therapies. The average office systolic/diastolic blood pressure levels were
significantly lower in the treated hypertensive patients than the untreated hypertensive
patients. The ACC/AHA guidelines (See Appendix A) were changed due to the
association of uncontrolled blood pressure and cardiac disease. With the new standards a
higher percentage of hypertensive patients who had been considered “under control” are
now classified as “uncontrolled.” The blood pressure control rate was reduced from 45
percent to 20 percent in the overall population sample. These findings prove the need to
treat hypertensive patients to prevent further complications of cardiovascular disease
related to the early diagnosis and management of hypertension. It was stated that due to
the limited time-lapse between data analysis and publication of new guidelines that it
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cannot be excluded that treating physicians have not modified their practice according to
new recommendations.
Tocci et al. (2020) used a large sample size for gathering their data. They also
identified the importance for hypertension to be managed earlier due to the correlation
between untreated hypertension and cardiovascular disease. This was applied to the
current research project by evaluating how the guidelines were utilized in managing and
treating patients with hypertension.
Carey et al. (2018) performed a study focused on several factors regarding
hypertension and treatments in adults which included how often hypertension occurs in
general, the recommended treatments, and how often the blood pressure is elevated above
the guidelines given by the 2017 ACC/AHA (See Appendix A) versus the use of the
seventh report of the Joint National Committee. According to the 2017 guidelines
provided by the American College of Cardiology/ American Heart Association, there are
specific parameters and recommendations for providers to follow for prevention, early
detection, and the treatment plan for adults diagnosed with hypertension. The 2017
AHA/ACC guidelines (See Appendix A) include parameters for the systolic and diastolic
blood pressure and has indicators on when to treat with antihypertensive medications.
Early detection and prevention and the appropriate management of hypertension are key.
The hypothesis of the study by Carey et al. (2018) was that the 2017 ACC/AHA
guidelines (See Appendix A) would significantly increase the diagnosis of patients with
hypertension in adults in the United States. To prove this hypothesis to be true, the adults
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in the study would need to be diagnosed with hypertension according to the 2017
ACC/AHA guidelines (See Appendix A) and given the appropriate treatment.
The study was conducted with adult participants using the National Health and
Nutrition Survey. The adults were required to be 20 years of age or older and without any
blood pressure readings during the study visit. Any participants who were missing selfreported data such as age, sex, tobacco use, or medication use were automatically
removed from the study. After all invalid participants were removed, the total number of
study participants was 9,623. Data was collected using questionnaires and clinic exams.
The questionnaire included two questions: 1.) Have you ever been told by a doctor or
other healthcare professional that you had hypertension, also called high blood pressure?
and 2.) Are you now taking prescribed medication for high blood pressure? In the clinic
exam, the blood pressure was taken by a trained doctor who used a mercury
sphygmomanometer and correct size cuff. The blood pressure cuff size was determined
by an arm measurement of each participant’s mid-right arm circumference to be the most
accurate. The participant was required to remain seated for 5 minutes. There were three
blood pressures obtained within thirty seconds of each other, then the mean of the three
was taken and used as the systolic blood pressure and diastolic blood pressure. The
quality control measures were constantly in place to ensure proper training was given.
The participants were then put into different groups which included: history of
cardiovascular disease and no history of cardiovascular disease with 10 year predicted
cardiovascular disease risk <5%, 5-10%, 10-20%, and greater than 20%.
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The study was successful in proving the hypotheses. Hypertension prevalence
increased to 45.6% when using the 2017 AHA/ACC guidelines (See Appendix A) in
comparison to 31.9% using the JNC7 (See Appendix D) guidelines in all categories such
as age, gender, race, and cardiovascular disease risk. Hypertension had a higher
occurrence when the 2017 AHA/ACC guidelines (See Appendix A) were used. There
were 36.2% of participants who were recommended to initiate hypertensive medication
using the 2017 AHA/ACC guidelines (See Appendix A) for treatment and management
of hypertension compared to the 34.3% who were using the JNC7 (See Appendix D)
guidelines for treatment and management.
This study was relevant to the current research project because it demonstrated that the
2017 AHA/ACC guidelines (See Appendix A) do increase the hypertension diagnosis
rate and it allowed the researchers to evaluate how well the 2017 AHA/ACC guidelines
(See Appendix A) were being followed by primary care providers in the clinic setting.
Han et al. (2019) performed a study from the 2017 ACC/AHA guidelines (See
Appendix A) that essentially lowered the hypertension diagnosis parameters. The study
estimates how starting early treatment for hypertension can significantly decrease the risk
for acute myocardial infarction, stroke, death, and the potential healthcare costs for the
patients according to the 2017 guidelines. The 2017 guidelines for blood pressure
parameters given by the American College of Cardiology provides specific regulations on
when to initiate treatment and what kind of treatment to begin. These guidelines
expanded the patient population for medication intervention. Hypertension is a growing
disease in the United States that also involves and affects other comorbidities such as
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hyperlipidemia, type 2 diabetes mellitus, chronic kidney disease, and cardiovascular
disease.
The study by Han et al. (2019) hypothesis was that the early initiation of
hypertension treatment can significantly decrease the patient’s risk for acute myocardial
infarction, stroke, death, and an increase in healthcare costs based on the 2017
ACC/AHA guidelines (See Appendix A). To prove the hypothesis, the participants in the
study would have a diagnosis of elevated blood pressure or would need to qualify for
treatment with antihypertensive medications using the 2017 ACC/AHA guidelines (See
Appendix A).
The study was conducted with adult participants using analysis from paid claims
data of a large health insurance provider in the US (Han et al., 2019). This was used to
establish patients that were considered high risk according to the guidelines provided by
the 2017 ACC/AHA (See Appendix A). The study included patients who either had
treatment after a major event related to cardiovascular disease or patients that did not
initiate any treatment with antihypertensive medications. The patients were required to
maintain health insurance at least six months prior to the study starting and twelve
months after their index date. Patients were excluded from the study if they were female
and pregnant, if they had filled or refilled any antihypertensive medications prior to their
diagnosis index date, or had a stroke, acute myocardial infarction, or any other major
cardiovascular disease event prior to their diagnosed index date. The data was reviewed
based on the patients’ baselines characteristics across treatments using the Pearson’s Chi
square test or t test. This allowed them to visualize the patients’ differences. It compared
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the use of antihypertensive drug use and the risk for cardiovascular disease events using
the Cox proportional hazards regression (Han et al., 2019). This identified the link
between the initiation of treatment and the time of the acute event. When analyzing the
impact of early intervention using antihypertensive medication on the cost for the three
different services used (medical, pharmacy, and total healthcare), the researchers used the
generalized linear model procedures. Three other areas were analyzed to provide more
extensive information regarding the early initiation of treatment. These areas included:
effects for patients with diabetes, chronic kidney disease, and obesity, patients treated
using only the initial antihypertensive medication and the outcomes, and antihypertensive
medication used in early intervention that was started within a 120-day window after the
diagnosis date.
The Han et al. (2019) study was successful in proving the hypothesis partially
correct. Early initiation of treatment with antihypertensive medications were noted to
significantly reduce the risk of a major cardiovascular event and death (Han et al., 2019).
Patients of the age of 75 and over were not likely to start antihypertensive therapy. Males
were less likely to start any intervention. The patients with an elevated blood pressure
were less likely to start treatment compared to patients with an actual hypertension
diagnosis. Patients with other comorbidities such as chronic kidney disease, type 2
diabetes, and hyperlipidemia were less likely to fill a prescription for antihypertensive
medication. The patients living in the South, West, and Midwest were more likely to
initiate treatment than those patients living in the Northeast. The results using the Cox
model stated that starting early treatment with antihypertensive medication prior to
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having a major cardiac event would significantly reduce the risk of stroke, death, and
acute myocardial infarction. When starting treatment prior to a major cardiac event, the
risk declines for acute myocardial infarction by 59%, stroke by 60%, and death by 10%.
Patients with a diagnosis of hyperlipidemia had a lower possibility of having an acute
myocardial infarction, stroke, and death which is thought to be due to their increased
understanding of their diagnosis of cardiovascular disease that could have led to positive
lifestyle changes. Hypertensive medication is also identified with lower healthcare costs.
The results regarding early treatment before 120 days of being diagnosed were not
significantly changed.
This study was applied to the current research project because it determined that
early intervention using the 2017 ACC/AHA guidelines (See Appendix A) prevented
major cardiac events, stroke, and death. This applies to the current research because of
the importance of knowledge in early diagnosing and managing patients with
hypertension. With the 2017 guidelines being stricter and broadening blood pressure
parameters, it makes the diagnosis of hypertension more likely. This study gave the
researchers something to compare and assess if primary care providers were able to
follow the guidelines when diagnosing and managing their patients with hypertension.
Warren-Findlow et al. (2020) performed a study to see if patients were adhering
to self-care behavior in managing their hypertension after the guidelines were changed to
diagnose and treat hypertension. The researchers utilized the revised 2017 guidelines
from the American College of Cardiology and American Heart Association. They
compared the new guidelines to the old guidelines of JNC7 (See Appendix D) from 2003
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and JNC8 from 2014. The researchers identified that hypertension is a major problem in
the US that is difficult to control with medication alone. The purpose of this study was to
assess the predictive ability of the Hypertension Self-Care Activity Level Effects (H
Scale) with respect to the management of hypertension. This study examined the relative
effects of the various hypertension self-care behaviors. The researchers believed that
self-care was a primary role to help prevent hypertension. The researchers also wanted to
investigate the relationship between adherence to hypertension self-care activities and the
control of blood pressure. No theoretical framework was identified for this study.
Warren-Findlow et al. (2020) had three questions to be answered. The questions
were as follows: 1.) Which self-care behavior should I focus on to get the greatest effect
on my blood pressure? 2.) How much self-care is enough to achieve control of my blood
pressure? and 3.) How much more benefit will I get from being adherent to additional
self-care behaviors? No hypothesis was identified.
JNC 7 lifestyle guidelines used the H-Scale questionnaire to assess levels of
adherence to antihypertensive medication compliance, physical activity engagement,
weight management, diet compliance, and avoidance of alcohol and tobacco. This same
questionnaire, H-Scale, was utilized for this study. A cross-sectional study pooled
baseline data from three intervention studies that were conducted in North Carolina.
These studies assessed blood pressure and self-care activities. Two studies incorporated
participants enrolled in intervention programs that included exercise training. The first
was a community-based study of 22 participants with hypertension randomized to a
group of participants that was using a home-based exercise program. The participants
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were aged from 21 to 60. Resting blood pressure was between 130/81 to 160/100 and the
participants were prescribed anti-hypertensive medications. The second study consisted
of 8 participants who had been diagnosed with hypertension and or cardiopulmonary
disease. Participants were randomized to either a control group or an exercise program.
The third study was conducted in a low-cost primary clinic. The participants were taking
at least one antihypertensive medication. Patients received brief intervention education to
improve healthy diets, medication adherence, and weight management. In all three
studies, the H-Scale date was used, and data was collected paper-based. All participants
had a diagnosis of HTN according to previous HTN guidelines recommended from the
JNC7 (See Appendix D) and JNC8 of >140/90 (See Appendix B). A timeline was not
given for this study; however, the questionnaire used asked about the past seven days.
There was a total of 79 participants in this study. Participants were, on average, in
their mid-50s. 54% were female, 34% were white, 33% were African American, and 30%
were Hispanic. This study presented an overall adherence for the recommended
hypertension self-care behaviors according to the JNC7 (See Appendix D) and JNC8
guidelines (See Appendix B). The 73 to 80% increased odds of blood pressure control for
adherence to each additional behavior contributed to the evidence supporting the
importance of counseling patients on HTN self-care. Based on this research, providers
should encourage patients to move more, along with medication compliance and diet
revision. Recommendations for future researchers were to have a larger sample size.
Knowing the patients’ BMI was also recommended.
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This study was applied to the research project by making note of the wide range
of the 2017 AHA/ACC (See Appendix A) parameters and their ability to diagnose
hypertension earlier. Lifestyle modifications are also required earlier using AHA/ACC
guidelines than the JNC 7/8. The 2017 AHA/ACC Hypertension Guidelines (See
Appendix A) implement more patient involvement and compliance due to patients
initiating medication sooner.
Yano et al. (2018) investigated if young adults diagnosed with hypertension who
met the blood pressure (BP) guidelines of the 2017 ACC/AHA (See Appendix A) before
the age of forty had a higher risk of a cardiovascular event compared to those that
maintained a normal blood pressure. The ACC/AHA (See Appendix A) lowered the
blood pressure guidelines and defined an elevated blood pressure as the clinic measured
systolic blood pressure of 120 mm Hg to 129 mm Hg and diastolic blood pressure less
than 80 mm Hg. Stage I hypertension was defined as clinic measured systolic blood
pressure (SBP) of 130 mm Hg to 139 mm Hg or diastolic blood pressure (DBP) of 80
mm Hg to 89 mm Hg. With these new changes, the blood pressure threshold for
hypertension was lowered from SBP/DBP of 140/90 mm Hg or higher and replaced it
with an SBP/DBP of 130/80 mm Hg or higher. With this change, there was an increase in
the prevalence of hypertension 2-fold to 3-fold for young adults. Non-pharmacological
and pharmacological interventions were recommended for adults with SBP/DBP of
140/90 (stage I hypertension) or higher and who had an estimated 10-year atherosclerotic
cardiovascular disease risk of 10 percent or higher. Most young adults with stage I
hypertension have a low 10-year atherosclerotic cardiovascular disease risk factor. The
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risk calculator was designed for adults 40 to 79 years old and is not recommended for
younger adults.
Yano et al. (2018) were concerned that if stage 1 hypertension is not associated
with major cardiac events in young adults, then the possible overdiagnosis of
hypertension could result in overtreatment in this age group. Yano et al. (2018) purpose
assessed whether adults who developed hypertension before the age of 40 have a higher
risk of major cardiovascular events later in life compared to those who maintained a
normal blood pressure of SBP less than 120 mm Hg and DBP greater than 80 mm Hg by
the age forty.
Yano et al. (2018) had one question. Do adults who develop hypertension, defined
by the 2017 ACC/ AHA (See Appendix A) blood pressure guidelines, before the age of
40 years have a higher risk for a cardiovascular event compared to those who maintained
a normal blood pressure? The Coronary Artery Risk Development in Young Adults
(CARDIA) study was used for the research. This study by Yano et al. (2018) consisted of
5,115 African American and Caucasian participants aged 18 to 30 from four United
States field centers that were registered in the CARIDA study in the years of 1985 and
1986. The field centers were in Birmingham, AL, Chicago, IL, Minneapolis, MI, and
Oakland, CA. The study excluded participants who had experienced CVD events before
age forty, participants that did not follow up before age of forty, and participants who
were missing blood pressure data needed for analysis. After the initial exam, the follow
up exams were required at two, five, seven, ten, fifteen, twenty, twenty-five, and thirty
years. During year zero to year fifteen, trained research staff measured the blood pressure
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three times in the participant's right arm at one-minute intervals after the participant had
been sitting in a quiet form for five minutes. The second and third measurement were
used for analysis. An automated oscillometric BP monitor was used during 20
examinations. Data such as race, height, weight, smoking status, physical activity,
medication used, history of diabetes, history of cardiovascular disease, and fasting lab
values were also obtained. The research staff collected information on hospitalizations,
outpatient medical procedures during examinations, and annual phone follow-ups. All
statistical analyses were performed with STATA, version 12.1.
Of the 5,115 participants, one participant withdrew consent, nineteen experienced
CVD events before the age of forty, thirteen participants were lost to follow-up, two
hundred and twenty participants had blood pressure measurements from only a single
exam, and eleven participants had missing covariates. The final sample size was 4,851.
The participants were categorized in groups as having a normal blood pressure (n=2574),
an elevated blood pressure (n=445), stage 1 hypertension (n=1195), and stage 2
hypertension (n=638). The average age when follow-up exams began was 35 years old.
Of the participants, 2,657 were women and 2.441 African American participants. During
the median follow-up, around18 to 19 years of age, 228 cardiovascular events took place
and 319 all-cause deaths occurred. All cardiovascular events and deaths occurred before
the age of sixty. The cumulative incidence of cardiovascular events was listed from
highest to lowest that included: stage 2 hypertension group with the highest risk, followed
by stage 1, elevated blood pressure group, and then the normal blood pressure group with
the lowest risk. The study concluded that among young adults, those with elevated blood

39
pressure, stage I hypertension, and stage 2 hypertension before age of 40 as defined by
the 2017 ACC/AHA guidelines (See Appendix A) had a significantly higher risk for
subsequent major cardiovascular events compared to those with normal blood pressure
before the age of forty.
The Yano et al. (2018) research project provides evidence that these new
guidelines set forth by ACC/AHA can help identify young adults at higher risk for CVD
events. This is relevant to the research project by making note of the stricter guidelines
set by the AHA/ACC (See Appendix A) and how it increases the prevalence of
hypertension. With these guidelines, it allows primary care providers to diagnose and
treat hypertension earlier which can prevent major risk factors from occurring such as
stroke, heart attack, or death. Having this knowledge is likely to motivate providers to see
the importance and benefits of adhering to the new guidelines.
Summary
Hypertension continues to rise in the United States. If untreated, there are
numerous health concerns that can occur that include heart attack or stroke, peripheral
artery disease, cardiomyopathies, kidney failure, or death. The current research project’s
purpose was to determine if nurse practitioners in MS are knowledgeable of the 2017
hypertension guidelines from the American Heart Association (See Appendix A). In the
Tocci et al. (2020) research study it was determined that using the 2017 ACC/AHA
guidelines (See Appendix A) increased the prevalence of hypertension. Hans et al (2019)
completed a research study that determined the importance of early treatment with
antihypertensive medications that could decrease a major cardiovascular event or death in
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patients. This suggested that early intervention when using the 2017 ACC/AHA
guidelines (See Appendix A) for treating and managing hypertensive patients could
prevent major cardiac events, stroke, and death. These research studies are relevant to the
current research because of the importance of understanding these hypertension
guidelines to properly diagnose and manage patients with hypertension. The purpose of
the current research study was to determine the knowledge of the primary care providers
of the 2017 ACC/AHA guidelines (See Appendix A) to diagnose and manage
hypertensive patients. These research studies confirm the need of determining the
knowledge of the primary care providers of the 2017 ACC/AHA guidelines (See
Appendix A).
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Chapter III
Design and Methodology
Introduction
Hypertension is considered a nationwide issue in the U.S. Treatment of
hypertension can reduce the risk of cardiovascular disease. (CDC, 2017). While
controlled hypertension is still a risk factor for cardiovascular diseases, patients and PCPs
can lower the together, regardless of whether or not the patient is aware of his or her
hypertension diagnosis. The American Heart Association guidelines for hypertension
were developed with nine health professional organizations and were published by a
panel of 21 scientists and health experts who reviewed more than 900 published studies
(AHA,2017). By amending the parameters of hypertension and beginning treatment
earlier the American Heart Association is trying to reduce cardiovascular disease and
complications.
The purpose of this research project was to determine if primary care providers in
Mississippi are knowledgeable of the 2017 American Heart Association Hypertension
Guidelines. The American Heart Association has stated that normal parameters for blood
pressure are a systolic and diastolic pressure of less than 120/80 mm Hg; elevated blood
pressure parameters are systolic pressures between 120-129 and a diastolic pressure less
than 80; stage one hypertension is defined by systolic pressures between 130-139 or
diastolic pressures between 80-89; stage two hypertension is defined by systolic pressures
of at least 140 or diastolic pressures at least 90 mm Hg; and a hypertensive crisis is
defined by a systolic pressure over 180 and/or diastolic pressures over 120 (AHA, 2017).
The 2017 American Heart Association Hypertension Guidelines have eliminated the
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category of prehypertension, categorizing patients as having either elevated (120-129 and
less than 80) or stage I hypertension (130-139 or 80-89). The earlier guidelines classified
140/90 mm Hg as Stage 1 hypertension, but this level has been amended as stage 2
hypertension under the new guidelines (AHA, 2017). Due to the revised hypertension
guidelines, the researchers wished to determine if Mississippi nurse practitioners were
knowledgeable of the most current guidelines when diagnosing and managing their
patients with hypertension. The population, setting, methods of data collection, and the
data collection tool (questionnaire) are presented in this chapter. The questionnaire is
seen in Appendix C.
Techniques for Data Collection
The researchers utilized a descriptive, quantitative questionnaire design to
evaluate the knowledge of Mississippi nurse practitioners regarding the 2017 American
Heart Association Hypertension Guidelines (See Appendix A). Through social media, the
researchers targeted specific Facebook groups for nurse practitioners that practice in the
state of Mississippi. Data gathered was web-based through SurveyMonkey. The
questionnaire was uploaded into SurveyMonkey, and the link for the questionnaire was
posted in the Facebook groups with an explanation of the research project. The design of
the study was appropriate given participant accessibility, time limited for data collection,
and the possibility of gaining relevant information through the chosen questionnaire
method. The questionnaire was available for one month to give the possibility for more
participants. The questionnaire is seen in Appendix C.
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Setting
The setting of this research study was web-based through social media. A brief
description of the project for recruitment of participants, included in Appendix E, and a
link to the questionnaire (See Appendix C) was uploaded to specific social media groups
on Facebook that were specifically for nurse practitioners in Mississippi. The inclusion
criteria were that the nurse practitioner practiced in the state of Mississippi, treated adult
patients, and had the potential to diagnose and/or manage hypertension.
Population and Sample
This research study was a quantitative study that surveyed nurse practitioners in
the state of Mississippi who accessed the SurveyMonkey questionnaire via Facebook
groups for nurse practitioners in the state of Mississippi. The identity of the participants
was unknown to the researchers. Once the questionnaire was completed, the data was
only made available to the researchers from SurveyMonkey’s database. No identifying
information was available. For the questionnaire to be considered for data analysis, the
participants had to have access to social media, be nurse practitioners who practiced in
the state of Mississippi, and be adequately equipped to diagnose or treat adult patients
with hypertension.
Procedures for Data Collection
This study was first approved by the Institutional Review Board of Mississippi
University for Women (IRB). The approval letter is included in Appendix F. The
researchers designed a questionnaire that evaluated the knowledge of the nurse
practitioners regarding diagnosing and managing their hypertensive patients according to
the 2017 American Heart Association’s hypertension guidelines. The questionnaire

44
included the parameters that were set by the 2017 American Heart Association.
Following its creation, the questionnaire’s link was distributed in various Facebook
groups that were specific for Mississippi nurse practitioners. It was made available until
April 31,2021.
The questionnaire (See Appendix C), created by the researchers included 14
multiple-choice questions. The first two questions determined if the participants’ answers
would be pertinent to the research project. The next question captured the experience of
the nurse practitioners. Questions 4-8 measured the nurse practitioners’ knowledge of
diagnosing hypertension according to the 2017 American Heart Association
Hypertension Guidelines. Questions 9-13 measured the nurse practitioners’ knowledge of
management of hypertension using the 2017 American Heart Association Hypertension
Guidelines. To be deemed knowledgeable in management and or diagnosing
hypertension, the nurse practitioners had to score 80 percent in that portion of the
questionnaire. The final question addressed how knowledgeable the nurse practitioners
thought they were on the 2017 American Heart Association Hypertension Guidelines.
The completed questionnaire results were then reviewed by the researchers for data
analysis.
Methods of Data Analysis
The data gathered from the completed questionnaire were then subjected to
analysis. Data were analyzed to determine if the nurse practitioner was knowledgeable of
blood pressure diagnosis and management according to the 2017 American Heart
Association Hypertension Guidelines. Data from the completed questionnaires were then
subjected to analysis using descriptive statistics that included percentages. To be deemed
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knowledgeable in management and or diagnosing hypertension the nurse practitioner had
to score 80% in that portion of the questionnaire. The ANOVA analysis method was used
to determine if there was any correlation between years of experience and if the nurse
practitioner was knowledgeable.
Summary
The purpose of this research project is to determine if primary care providers in
Mississippi are knowledgeable of the 2017 American Heart Association Hypertension
Guidelines with respect to diagnosing adult hypertensive patients and management of
adult hypertensive patients. This was determined by publishing a questionnaire through
SurveyMonkey. A link was published on social media that targeted specific Facebook
groups for nurse practitioners that practice in Mississippi.
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Chapter IV
Presentation of Findings
During 2015–2016, the prevalence of hypertension in the United States was
29.0% in the United States and increased with age: age group 18–39 was estimated to be
at 7.5%; age 40–59 was estimated to be at 33.2%; and age 60 and over was estimated to
be 63.1% (CDC, 2017). Untreated or uncontrolled hypertension can lead to a higher risk
for other health threats such as heart attack, heart disease, stroke, kidney failure,
peripheral artery disease, and many other disease processes. When hypertension is
controlled, the risk of cardiovascular disease can be lowered. Regular blood pressure
screening and education of an individual’s blood pressure target range should be an
important aspect of being a healthcare provider today. The purpose of this research
project was to determine if primary care providers in Mississippi are knowledgeable of
the 2017 American Heart Association Hypertension guidelines (See Appendix A).
The research questions were as follows:
1.

Are primary care providers knowledgeable of the 2017 American Heart

Association Hypertension Guidelines for diagnosing adult patients with
hypertension? (See Appendix A)

2.

Are primary care providers knowledgeable of the 2017 American Heart

Association Hypertension Guidelines for the management of adult patients
diagnosed with hypertension? (See Appendix A)
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Participant Characteristics
60 total questionnaires were completed by participants. Only nurse practitioners
were targeted to participate in the questionnaire. The questionnaire was placed on social
media in Facebook groups specifically for nurse practitioners. Responses were removed
if the nurse practitioner was not currently managing and diagnosing adult patients with
hypertension in Mississippi. The remaining total sample size was 52.
The questionnaire (See Appendix C), created by the researchers included 14
multiple-choice questions. The first two questions captured if the participant’s survey
would be viable for the research project. Question number one of the questionnaire asked
if the nurse practitioner currently practiced in Mississippi. Two participants answered
no; 58 answered yes (N=58), shown in Figure 1. Question two asked if the nurse
practitioner was currently diagnosing and managing adult patients eighteen years and
older with hypertension. Seven nurse practitioners answered no and fifty-three answered
yes (N=53), shown in Figure 2. One practitioner answered no to both, which resulted in a
total of 52 viable questionnaires. Question three of the questionnaire asked the nurse
practitioner to report their years of experience. The researchers would later look at this
data to see if there was a correlation between the provider's knowledge and years of
experience. Approximately 53% of the nurse practitioners had five years or less of
experience, 23% of the nurse practitioners had five to ten years of experience, 15% of the
nurse practitioners had ten to twenty years of experience as a nurse practitioner, and 8%
of the nurse participants had twenty years or more of experience as a nurse practitioner.
The years of experience are shown in Figure 3.
Question number one of the questionnaire asked if the nurse practitioner currently
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practiced in Mississippi. Two participants answered no; 58 answered yes (N=58).
Figure 1
Nurse Practitioners currently practicing in Mississippi

Yes

No

Question two asked if the nurse practitioner was currently diagnosing and
managing adult patients eighteen years and older with hypertension. Seven nurse
practitioners answered no, and 53 answered yes (N=53). One participant answered no to
both demographic questions; therefore, this participant’s answers were not included in the
results.
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Figure 2
Nurse practitioners diagnosing and managing adult hypertensive patients

Yes

No

Approximately 53% of the nurse practitioners had five years or less of experience,
23% of the nurse practitioners had five to ten years of experience, 15% of the nurse
practitioners had ten to twenty years of experience, and 8% of the nurse participants had
twenty years or more of experience as a nurse practitioner. The years of experience are
shown in Figure 3.
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Figure 3
Nurse Practitioners Years of experience

1-5 years

5-10 years

10-20 years

20+ years

Findings
The findings evaluated the knowledge of the nurse practitioners in regard to
diagnosing and managing hypertension based on the 2017 American Heart Association
Hypertension Guidelines (See Appendix A). This was determined by using a
questionnaire posted on SurveyMonkey (See Appendix C).
To determine if nurse practitioners were knowledgeable of the 2017 American
Heart Association Hypertension Guidelines, (See Appendix A) a questionnaire (See
Appendix C) was utilized with certain criteria that had to be met to be considered
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knowledgeable of the 2017 AHA/ACC guidelines (See Appendix A). Questions 4-8 and
questions 9-13 assessed the nurse practitioners’ knowledge of diagnosing and managing
hypertension according to the 2017 American Heart Association Hypertension Guidelines
(See Appendix A). To be considered knowledgeable in diagnosing hypertension the
nurse practitioner had to score 80% or higher on questions 4-8. To be considered
knowledgeable in management of hypertension, the nurse practitioner had to score an
80% or higher on questions 9-13.
Table 1
Diagnostic Knowledge: Number of questions answered correctly

# Correct

F

%

Cumulative
%

1

5

9.6

9.6

2

3

5.8

15.4

3

14

26.9

42.3

4

21

40.4

82.7

5

9

17.3

100.0

(N=52)

A table of scores for questions 4-8 are shown in Table 1. This represents the
questions answered correctly by the nurse practitioners. The lowest possible score value
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is zero, which would mean no correct answers were chosen. The highest possible score
value is five. This would reflect correct answers for the diagnostic portion of the
questionnaire. Four of five questions answered correctly was required to be considered
knowledgeable. Approximately 57.7% of the nurse practitioners were considered
knowledgeable in diagnosing patients with hypertension using the 2017 American Heart
Association Hypertension Guidelines (See Appendix A). More than half of the nurse
practitioners who participated scored greater than 80% on this portion of the
questionnaire and were considered knowledgeable of diagnosing hypertension according
to the 2017 American Heart Association Hypertension Guidelines (See Appendix A). 21
nurse practitioners answered four questions correctly, and nine answered five questions
correctly. Out of 52 nurse practitioners, 30 were considered knowledgeable of diagnosing
hypertension according to the 2017 American Heart Association Hypertension Guidelines
(See Appendix A).
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Table 2
Management Knowledge: Number of questions answered correctly.

# Correct

F

%

Cumulative %

1

1

1.9

1.9

2

9

17.3

19.2

3

14

26.9

46.2

4

27

51.9

98.1

5

1

1.9

100

(N=52)

A table of the scores for questions 9-13 are shown in Table 2. This represents the
questions answered correctly by the nurse practitioners. The lowest possible score value
is zero, which would mean no correct answers were chosen. The highest possible score
value is five. This would reflect the correct answers for the management portion of the
questionnaire. Four of five questions answered correctly were required to be considered
knowledgeable. More than half of the nurse practitioners who participated scored greater
than 80% on the questionnaire and were considered knowledgeable of managing
hypertension according to the 2017 American Heart Association Hypertension Guidelines
(See Appendix A). 27 nurse practitioners answered four questions correctly, and one
answered five correctly. Out of 52, 28 nurse practitioners were considered knowledgeable
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in managing hypertension according to the 2017 American Heart Association
Hypertension Guidelines (See Appendix A).
Additional Findings
Figure 4
Management and Diagnostic Knowledge: Numbers of questions answered compared with

Number of questions answered correctly

experience.

30.00
25.00
20.00
15.00
10.00
5.00
0.00
1-5 years

5-10 years

10-20 years

20+ years

Years of experience

Figure 4 shows the correlation between years of experience compared to the nurse
practitioners who were knowledgeable in a combination of diagnosing and managing
hypertension using the 2017 American Heart Association Hypertension Guidelines (See
Appendix A). Somers’d was utilized to determine if there was any correlation between
years of experience and knowledge of both the diagnosing and management portions of
the questionnaire. As the years of experience increased, the overall score of the
questionnaire decreased. Therefore, there was a weak negative correlation because it
determined that novice nurse practitioners essentially scored higher on the questionnaire
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than veteran nurse practitioners. 28 nurse practitioners with one to five years of
experience averaged 7.1429 correct answers. 12 nurse practitioners with five to ten years
of experience averaged 7.0833 correct answers. 8 practitioners with ten to twenty years of
experience averaged 6.00 correct answers. 4 nurse practitioners with twenty years or
greater of experience averaged 5.7500 correct answers. The nurse practitioners with one
to five years of experience had the highest mean average of 7.1429 of correct answers.
Summary
The sample for the current research study included nurse practitioners who
currently treat adult hypertensive patients in the state of Mississippi. The purpose of this
research project was to determine if primary care providers in Mississippi are
knowledgeable of the 2017 American Heart Association Hypertension Guidelines (See
Appendix A). Questionnaires were removed from the results if the nurse practitioner was
not currently diagnosing and managing adult hypertensive patients and if the nurse
practitioner was not practicing in the state of Mississippi. This left a total sample of fiftytwo questionnaires. Most of these questionnaires were completed by nurse practitioners
with less than five years of experience. Questions 4-8 measured the nurse practitioners’
knowledge of diagnosing hypertension according to the 2017 American Heart
Association Hypertension Guidelines (See Appendix A). Approximately 57% of the
nurse practitioners were considered knowledgeable in diagnosing hypertension.
Questions 9-13 measured the nurse practitioner's knowledge of managing hypertension
according to the 2017 American Heart Association Hypertension Guidelines (See
Appendix A). Approximately 54% were considered knowledgeable of managing
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hypertension. Based on the results, nurse practitioners are knowledgeable of the 2017
American Heart Association Hypertension Guidelines (See Appendix A).
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CHAPTER V
Conclusions, Implications, and Recommendations
Untreated or uncontrolled hypertension can lead to a higher risk for other health
threats such as heart attack, stroke, kidney failure, peripheral artery disease, and many
other diseases. The purpose of this research project was to determine if primary care
providers in Mississippi are knowledgeable of the 2017 American Heart Association
Hypertension Guidelines (See Appendix A) in order to diagnose and manage patients
with hypertension. Controversial viewpoints regarding hypertension exist between
healthcare providers who support the 2017 AHA/ACC (See Appendix A) guidelines and
the JNC 8 guidelines (See Appendix B). Some providers claim that the revised 2017
American Heart Association hypertension guidelines, included in Appendix A, only skew
the numbers of patients diagnosed with hypertension, considering the threshold is lower
than the JNC 8 guidelines. These healthcare providers who are not supportive of the 2017
American Heart Association hypertension guidelines are more supportive of the Joint
National Committee 8 hypertension guidelines that were published in 2013 (Page, 2014).
The Joint National Committee (JNC 8) guidelines, published in 2013, advise higher blood
pressure levels and less use of several types of antihypertensive medications.
The current researchers sought to assess the knowledge of nurse practitioners in
Mississippi of the 2017 American Heart Association Hypertension guidelines (See
Appendix A). Sister Callista Roy’s Adaptation Model was the theoretical framework
used to guide this study. Once the framework was determined, the researchers utilized a
descriptive, quantitative questionnaire to evaluate the knowledge of Mississippi nurse
practitioners regarding the 2017 American Heart Association Hypertension Guidelines
(See Appendix A). Through social media, the researchers targeted specific Facebook
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groups for nurse practitioners that practice in the state of Mississippi. Data gathered was
web-based through SurveyMonkey. This chapter summarizes, interprets, and reviews the
study conducted. Limitations, conclusions and implications are also reviewed.
Recommendations based on these factors are included for future clinical research studies.
Summary of the Investigation

The sample studied in this project consisted of nurse practitioners that currently
treat adult hypertensive patients in the state of Mississippi. Questionnaires were removed
from the sample if the nurse practitioner was not currently diagnosing and managing
adult hypertensive patients and if the nurse practitioner was not practicing in the state of
Mississippi. A total sample of 52 questionnaires were left for research purposes.
Questions 4-8 of the questionnaire measured the nurse practitioner's knowledge of
diagnosing hypertension according to the 2017 American Heart Association hypertension
guidelines (AHA/ACC) (See Appendix A). Questions 9-13 measured the nurse
practitioner's knowledge of managing hypertension according to the 2017 American
Heart Association hypertension guidelines (See Appendix A). Out of 52 total
participants, 30 practitioners were considered knowledgeable of diagnosing hypertension
according to the 2017 American Heart Association Hypertension Guidelines (See
Appendix A). Twenty-eight of fifty-two nurse practitioners were considered
knowledgeable in managing hypertension using the 2017 American Heart Association
Hypertension Guidelines (See Appendix A). Based on the results, overall nurse
practitioners are knowledgeable of the 2017 American Heart Association Hypertension
Guidelines.
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Interpretations of Findings with Conclusions

Primary care providers face the challenge of remaining properly educated on the
current guidelines for the diagnosis and management of hypertension while also
educating patients on the importance of these aspects of their illness. Patients will need
further education on the 2017 American Heart Association Hypertension Guidelines (See
Appendix A) and the changes that were recommended in comparison to the JNC 8
guidelines (See Appendix B).

Most of the questionnaires (See Appendix C) were completed by nurse
practitioners with less than five years of experience. Approximately 57% of nurse
practitioners who completed the questionnaire were considered knowledgeable of
diagnosing hypertension, while approximately 54% of the nurse practitioners who
completed the questionnaire were considered knowledgeable of managing hypertension
patients. Based on the results from the questionnaire, nurse practitioners in Mississippi
are knowledgeable of the 2017 American Heart Association Hypertension Guidelines
(See Appendix A) in regards to diagnosing and management patients with hypertension

The current researchers compared the results of the current research with previous
studies. These studies regarding hypertension guidelines were reviewed by the current
researchers. Mohaissen et al. (2020) assumed that the prevalence of hypertension
markedly increased among their population in Saudi using the 2017 American Heart
Association Guidelines (See Appendix A). This assumption was statically correct. Using
the 2017/ACC/AHA (See Appendix A) classification, 27.1 percent of participants would
be classified as having hypertension, which is significantly higher than the prevalence of
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4.1 percent if the JNC7 (Appendix D) classification was used. Mohaissen, et al. (2020)
found that 85% of the hypertensive patients in this study had stage 1 hypertension and
15% had stage 2 hypertension. Hypertension cases based on the new classification will
increase the disease prevalence and management burden on the healthcare system
requiring more interventions and education by healthcare providers. Therefore, it is
important for primary care providers to be knowledgeable of these new guidelines to be
able to adequately diagnose and manage their hypertensive patients. This study does not
evaluate the knowledge of the providers in regard to the 2017 American Heart
Association Hypertension Guidelines (See Appendix A). It only evaluates the prevalence
of hypertension using the 2017 American Heart Association Hypertension Guidelines
(See Appendix A). It does support that utilizing the 2017 American Heart Association
Hypertension Guidelines (See Appendix A) did increase hypertension prevalence.
Adibelli et al. (2018) completed a study to evaluate patients diagnosed with
hypertension that were provided with education management by using Roy’s Adaptation
Model. Their study was to evaluate the effectiveness of education in patients diagnosed
with hypertension using Roy’s adaptation model for hypertensive management. This
research determined the effectiveness of appropriate teaching provided to patients with
hypertension. This study noted that adaptation was beneficial for detection, prevention,
and treatment of hypertension. This is relevant to the current research in regard to how
the nurse practitioners have adapted to the new hypertension guidelines provided by the
American Heart Association (See Appendix A). In the current research, it was determined
that there was weak correlation between experience and success rates of the surveys;
newer nurse practitioners were determined to be more knowledge of the 2017 AHA/ACC
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Hypertension Guidelines (See Appendix A) than the nurse practitioners with more
experience. Therefore, as the years of experience increased, the questionnaire scores
declined. One possible reason is that the nurse practitioner with more years of experience
may be more comfortable with older models and methods of diagnosing and managing
hypertension as they have been using JNC 8 guidelines for a longer period of time (See
Appendix B).
Tocci et al. (2020) performed a study to investigate whether patients were being
treated for hypertension based on the most recent European guidelines. The new
guidelines provided from the European Society of Cardiology/European Society of
Hypertension (ESC/ESH) were comparable to the 2017 American Heart Association
Hypertension Guidelines (See Appendix A). Their purpose was to determine if blood
pressures were diagnosed and treated following their new guidelines. The researchers
identified the importance for hypertension to be managed earlier due to the correlation
between untreated hypertension and cardiovascular disease. This study did not evaluate
the knowledge of the providers. It only evaluated the use of the ESC/ESH guidelines that
are comparable to the 2017 American Heart Association Hypertension Guidelines (See
Appendix A). This was noted to redefine hypertension and those that were considered
“controlled” were then classified as “uncontrolled.” Therefore, it would support that the
use of the 2017 American Heart Association Hypertension Guidelines (See Appendix A)
increases the prevalence of hypertension.
Yano et al. (2017) investigated if young adults diagnosed with hypertension who
met the blood pressure (BP) guidelines of the 2017 ACC/AHA (See Appendix A) before
the age of forty had a higher risk of a cardiovascular event compared to those that
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maintained a normal blood pressure. The ACC/AHA (See Appendix A) lowered the
blood pressure guidelines and defined an elevated blood pressure as the clinic measured
systolic blood pressure of 120 mm Hg to 129 mm Hg and diastolic blood pressure less
than 80 mm Hg. Stage I hypertension was defined as clinic measured systolic blood
pressure (SBP) of 130 mm Hg to 139 mm Hg or diastolic blood pressure (DBP) of 80
mm Hg to 89 mm Hg. With these new changes, blood pressure threshold for hypertension
was lowered from SBP/DBP of 140/90 mm Hg or higher and replaced it with an
SBP/DBP of 130/80 mm Hg or higher. With this change, there was an increase in the
prevalence of hypertension 2-fold to 3-fold for young adults. Yano et al. (2018) were
concerned that if stage 1 hypertension is not associated with major cardiac events in
young adults that the possible overdiagnosis of hypertension could result in overtreatment
in this age group. The study by Yano et al. (2018) had 5115 African American and
Caucasian participants aged 18 to 30 from four United States field centers that were
registered in the CARIDA study in the years of 1985 and 1986. Of the 5115 participants,
one participant withdrew consent, nineteen experienced CVD events before the age of
forty, thirteen participants were lost to follow-up, two hundred and twenty participants
had blood pressure measurements from only a single exam, and eleven participants had
missing covariates. The final sample size was 4851. The study concluded that among
young adults, those with elevated blood pressure, stage I hypertension, and stage 2
hypertension before age of 40 as defined by the 2017 ACC/AHA guidelines (See
Appendix A) had a significantly higher risk for subsequent a major cardiovascular event
compared to those with normal blood pressure before the age of forty. With these
guidelines, it allows primary care providers to diagnose and treat hypertension earlier
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which can prevent major risk factors from occurring such as stroke, heart attack, or death.
With this knowledge, it can motivate providers to see the importance and benefits of
adhering to the new guidelines. Their study did not evaluate the knowledge of the
providers. Their study did investigate if young adults diagnosed with hypertension met
the blood pressure guidelines of the 2017 ACC/AHA (See Appendix A) noting that
before the age of forty had a higher risk of a cardiovascular event compared to those that
maintained a normal blood pressure (See Appendix A). Therefore, this study does support
teaching the new guidelines to the nurse practitioners for them to use in the future.
After reviewing literature and comparing results to the current research study, the
current researchers determined there is need for further research in regard to the
knowledge of nurse practitioners in regard to the 2017 American Heart Association
Hypertension Guidelines (See Appendix A). Nurse practitioner’s knowledge of the 2017
American Heart Association Hypertension Guidelines (See Appendix A) could prevent
health related risks that could potentially cause further complications or death. Because
the current sample size was limited, it was difficult to determine the knowledge deficits
of nurse practitioners. As knowledge deficits are unknown, further research and
education is needed to continue to assess the knowledge of nurse practitioners. Once
research results were obtained and the knowledge level was determined, the researchers
could provide information and education to the nurse practitioners to improve their
knowledge of the 2017 American Heart Association’s Hypertension Guidelines (See
Appendix A).
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Limitations of the Research
Several limitations were identified throughout the duration of this project. The
limitations were a small sample size, geographically limited data collection, and a short
time frame for data collection. Surveys were removed from the sample if the nurse
practitioner answered that they were not currently diagnosing and managing adult
hypertensive patients and if the nurse practitioner stated that they were not practicing in
the state of Mississippi. This limited the sample size, therefore limiting the data gathered
to a smaller number of participants. Another limitation was the number of individuals
who were reached by social media. Many nurse practitioners in Mississippi are not on
social media. Some nurse practitioners may not be included or involved in the Facebook
groups where the survey link was posted. This limitation limited the number of
participants taking the survey.
Overall, there were several factors that limited the researchers’ results. The results
were affected by the small sample size, the geographically limited data collection, and the
short time frame for data collection. All of these factors hindered the results from
possibly being more specific to represent the population adequately.
Implications and Recommendations
While controlled hypertension is a risk factor for cardiovascular diseases, the risk
can be lowered and should be a priority for anyone with a known diagnosis of
hypertension. The 2017 American Heart Association Hypertension Guidelines (See
Appendix A) were developed to control hypertension in a way that will lead to less
cardiac events and other comorbidities.
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There are many implications for research that can be drawn in the future from the
findings of this study. Although the results determined that nurse practitioners in
Mississippi were knowledgeable of the 2017 American Heart Association Hypertension
Guidelines (See Appendix A) with diagnosing and managing hypertensive patients, the
review of literature was limited. A larger sample size could determine a truer
determination of knowledge of the guidelines. The American Heart Association is always
doing further research to develop updated guidelines. This study could be used for
comparison in the future if the American Heart Association develops a new set of
hypertension guidelines (See Appendix A).
The purpose of this project was to determine the knowledge of nurse practitioners
in regard to the 2017 American Heart Association Hypertension Guidelines (See
Appendix A). This project determined nurse practitioners were knowledgeable of the
2017 American Heart Association Hypertension Guidelines (See Appendix A).
Recommendations
Based on the results of this project, the following recommendations are made:
1. Increase the sample size to more accurately represent the population.
2. Make the survey available for a longer period of time to increase the number of
completed surveys and participants.
3. Further research regarding the knowledge of the 2017 American Heart
Association Hypertension Guidelines with a larger sample size along with
alternate ways of distributing the survey or other data-gathering method
4. Through education, increase the knowledge of the 2017 American Heart
Association Hypertension Guidelines.
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Appendix A
2017 American Heart Association Hypertension Guidelines
Normal
Blood
Pressure

Elevated
Blood
Pressure

Stage I Hypertension

BP
<120/80
mm Hg

BP 120-129/
< 80 mm Hg

BP 130-139/ 80-89 mm Hg

Promote
optimal
lifestyle
habits

Non
pharmacologic
therapy Class 1

Clinical or estimated
Atherosclerotic Cardiovascular
disease risk factors > 10%
No

Reassess in
1 year

Reassess in 3-6
months

Stage II
Hypertension

BP > 140/90 mm
Hg

Yes

Nonpharmacological
therapy

NonAnd
pharmacological
NonBP lowering
therapy
pharmacological
medication Class
&
therapy
I
BP lowering
medication.
Reassess in 3-6
months

Reassess in 1
month

Reassess in 1
month

Goal Met
No

Yes

Assess and
optimize
adherence to
therapy

Reassess in 3-6
months

Consider
intensification of
therapy
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Appendix B

Comparing JNC 8 hypertension guidelines
vs.
AHA/ACC hypertension guidelines.

Eighth Joint National
Committee Hypertension
Guidelines

American Heart Association/
American College of Cardiology
Hypertension Guidelines

Optimal BP
< 120/ < 80

Normal BP
< 120 / < 80

Normal BP
120-129 and/or 80-84

Elevated BP
120-129 / < 80

High Normal
130-139 and/or 85-89

Stage I Hypertension
130-139 / 80-89

Grade 1 Hypertension
140-159 and/or 90-99
Grade 2 Hypertension
160-179 and/or 100-109

Stage II Hypertension
> 140 / > 90

Grade 3 hypertension
>180 and/or >110

Hypertensive crisis
> 180 / > 120
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Appendix C
Questionnaire for MS nurse practitioners:
1. Are you a nurse practitioner currently practicing in Mississippi?
a. Yes
b. No
2. Are you currently diagnosing and managing adult patients 18 years and older with
hypertension?
a. Yes
b. No
3. How many years of experience as a nurse practitioner have you had?
a. 1-5 years
b. 5-10 years
c. 10-20 years
d. 20+ years
4. Of these blood pressure readings, using the 2017 American Heart Association
guidelines, which would you consider requiring treatment with medications after
nonpharmacological interventions were unsuccessful?
a. 138/89 à new AHA guidelines
b. 145/90
c. 119/79
d. 181/95
5. Which of these blood pressure readings would be considered controlled with
medications using the 2017 American Heart Association Guidelines?
a. 130/90
b. 118/78
c. 140/85
d. 145/85
6. A patient has Stage 1 HTN, a BP of 130/89, the patient has an estimated 10-year
CVD risk > 10% due to their risk factors, which of these interventions would you
initiate for this patient using the 2017 American Heart Association guidelines?
a. Reassess in 1 year
b. Reassess in 3 months
c. Nonpharmacologic therapy
d. Nonpharmacologic therapy & BP lowering medication
7. If a patient has an elevated blood pressure of 129/89, using the 2017 American
Heart Association guidelines when would you reassess this patient when using
nonpharmacological treatment?
a. 3-6 months
b. 9-12 months
c. 1 years
d. Does not require follow up.
8. Which of these blood pressures would be considered Stage 1 hypertension using
2017 American Heart Association guidelines?
a. >140 or >90
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b. <120/80
c. 130-139 or 80-89
d. None of the above.
9. Using the 2017 American Heart Association guidelines, if a patient has a BP
reading of >140/ >90 which one of these would you implement?
a. Nonpharmacological therapy
b. 2 BP lowering agents
c. 1 BP lower agent
d. Both A & B
e. Both A & C
10. Which of these blood pressure would be considered Stage 2 hypertension using
2017 American Heart Association guidelines?
a. >/= 140 or >/= 90
b. 130-139 or 80-89
c. <120/80
d. None of the above
11. A patient has a BP reading of 129/89, using the 2017 American Heart
Association’s guidelines, how would you stage this BP reading?
a. Stage II Hypertension
b. Elevated BP
c. Normal BP
d. Stage I hypertension
12. A patient presents to your clinic with complaints of recent increase in BP with
headaches and has the following BP diary over the last 3 days: 136/80; 134/88;
138/86. The patient is not on BP lowering medications. Which intervention would
you use first using the 2017 American Heart Association guidelines?
a. Initiate 2 BP lowering agents
b. Initiate 1 BP lowering agent
c. Nonpharmacological therapy
d. Reassess in 3-6 months
13. According to the 2017 American Heart Association guidelines, which of these
statements are correct?
a. A patient has an elevated BP. It would be appropriate to follow up in 1
year.
b. A patient has reported an elevated BP for 1 week. At the visit his BP is
146/78, he should not be started on a blood pressure lowering agent.
c. When initially starting BP medications, it is appropriate to follow up in 1
month for reevaluation.
d. A patient is managed well with their BP lowering agents. It would be
appropriate to follow up in 1 year.
14. On a scale of 1-4, how knowledgeable are you of the 2017 American Heart
Association hypertension recommendations?
a. 1- None/LOW
b. 2- Basic
c. 3- Proficient
d. 4 – Expert
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Appendix D
Seventh Joint National Committee Guidelines
(JNC7)
Classification of Blood Pressure
Category

Systolic

Diastolic

Normal

<120

<80

Prehypertension

120-139

80-89

Hypertension, Stage I

140-159

90-99

Hypertension, Stage II

>160

>100
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Appendix E
Description of project for recruitment for nurse practitioners’ participation in
questionnaire.

We are a research group of graduate students currently enrolled at the Mississippi
University for Women. As part of our curriculum in the Master of Science in the Family
Nurse Practitioner program we are required to complete a research project. Our project is
to evaluate the knowledge of the 2017 American Heart Association hypertension
guidelines in nurse practitioners in Mississippi. We invite you to click on the link to our
survey and complete the multiple-choice questionnaire. The information collected
through SurveyMonkey will remain anonymous. Participation in this survey is
completely voluntary. Thank you in advance for your time and assistance with this
research study.
Sincerely,
Kelsey Creel, Kristan Kelly, and Linda Turner
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Appendix F

March 26, 2021
tjhamill@muw.edu

Dear Dr. Hamill:
I am pleased to inform you that the members of the Institutional Review
Board (IRB) havereviewed the following proposed research and have
approved it as submitted:
Name of Study: Knowledge of the 2017 American Heart Association
hypertension guidelines”
Research Faculty/ Advisor: Terri Hamill
Investigators: MSN Research Group

I wish you much success
in your research.
Sincerely,

Scott Tollison, Ph.D.
Provost and Vice President for
Academic AffairsST/tc
pc: Irene Pintado, Institutional Review Board Chairman

